香港联交所最新资料显示，1月27日，PACIFIC LEGEND(08547)股东将股票由泉涌证券转入实德证券， 转仓市值239.69万港元，占比5.13%。 同日，PACIFIC LEGEND发布公告，董事会建议按每持有2股股份获发1股供股股份的基准，以认购价每 股供股股份0.10港元进行供股事项，透过向合资格股东发行最多2.96亿股供股股份的供股方式筹集所得 款项总额约2960万港元。供股事项仅供合资格股东认购，将不会向除外股东提呈。认购价较本公告日期 于联交所所报的收市价每股0.0800港元溢价约25.00%。 ...

如获悉数认购，供股事项估计所得款项净额于扣除所有必要开支后估计将约为2810万港元。公司拟将供 股事项所得款项净额用作以下用途：约34%用于偿还与向一名独立第三方认购的本金额为人民币1000万 元并于2026年3月27到期的无抵押应付债券相关的借款，预期该借款将于供股事项完成前获再融资或延 期，而所得款项净额将用于其后偿还该再融资或延期的借款。基于公司现行资金规划，并视乎与相关贷 款人的磋商结果及现行市况，公司拟于应付债券到期时，透过寻求现有应付债券的短期延期，或以其他 短期借款再融资应付债券，以应付其短期资金需求。公司亦拟于收取供股事项所得款项后偿还再融资或 延期的借款;约18%用于支付租金开支(包括应计租金开支);约18%用于迪拜项目(该项目为阿联酋员工宿 舍提供家具，为期至少三年);约7%用于在香港开设一间新零售店舖;及余下约23%用作集团的一般营运 资金，以支付薪金、供应商款项及其他运营与行政开支。 智通财经APP讯，PACIFIC LEGEND(08547)发布公告，董事会建议按每持有2股股份获发1股供股股份的 基准，以认购价每股供股股份0.10港元进行供股事项，透过向合资格股东发行最多2.96亿股 ...

Group 1 - The company, PACIFIC LEGEND (08547), announced a rights issue offering 1 share for every 2 shares held at a subscription price of HKD 0.10 per share, aiming to raise approximately HKD 29.6 million through the issuance of up to 296 million shares to eligible shareholders only [1] - The subscription price represents a premium of approximately 25.00% over the closing price of HKD 0.0800 on the announcement date [1] Group 2 - If fully subscribed, the estimated net proceeds from the rights issue, after deducting all necessary expenses, are expected to be around HKD 28.1 million [2] - The company plans to allocate approximately 34% of the net proceeds to repay a loan related to an unsecured bond of RMB 10 million due on March 27, 2026, which is expected to be refinanced or extended before the completion of the rights issue [2] - Approximately 18% of the net proceeds will be used to cover rental expenses, another 18% for a Dubai project providing furniture for employee accommodation, about 7% for opening a new retail store in Hong Kong, and the remaining approximately 23% for general operating funds, including salaries and supplier payments [2]

澳门励骏(01680)发布公告，于2026年1月23日，依本公司的供股事项，以每持有2股现有股份获发1股供 股股份的基准，以每股供股股份认购价港币0.3元，办理供股股份的配发及发行3.1亿股供股股份。 ...

智通财经APP讯，浩柏国际(08431)发布公告，根据供股提呈发售1.82亿股供股股份。董事会宣布，于 2026年1月19日(星期一)下午四时正(即接纳供股股份的截止时间)，已收到合共7份有效接纳，涉及合共 4045.08万股供股股份，相当于发售股份总数的约22.23%。因此，供股认购不足额为1.42亿股供股股 份，相当于发售股份总数的约77.77%，相关股份将根据补偿安排处理。 配售代理将按尽力基准，在不迟于2026年1月30日( 星期五)下午六时正促使承配人认购所有(或尽可能多 的)该等未获认购供股股份及除外股东未售出供股股份。 ...

SHANGHAI GROWTH(00770)发布公告，董事会建议(其中包括)按于记录日期每持有8股股份获发3股供 股股份按认购价每股供股股份0.12美元进行供股，以透过向合资格股东提呈最多480.87万股供股股份的 供股方式筹集扣除开支前所得款项总额约58万美元(假设于记录日期或之前概无进一步发行或购回股 份)。如获悉数认购，供股估计所得款项净额于扣除所有必要开支后估计将约为55万美元。 ...

智通财经APP讯，SHANGHAI GROWTH(00770)发布公告，董事会建议(其中包括)按于记录日期每持有 8股股份获发3股供股股份按认购价每股供股股份0.12美元进行供股，以透过向合资格股东提呈最多 480.87万股供股股份的供股方式筹集扣除开支前所得款项总额约58万美元(假设于记录日期或之前概无 进一步发行或购回股份)。 如获悉数认购，供股估计所得款项净额于扣除所有必要开支后估计将约为55 万美元。 ...

如获悉数认购，供股估计所得款项净额于扣除所有必要开支后估计将约为55万美元(假设于记录日期或 前概无进一步发行或购回股份)。 格隆汇1月15日丨SHANGHAI GROWTH(00770.HK)公告，董事会建议(其中包括)按于记录日期每持有八 (8)股股份获发三(3)股供股股份按认购价每股供股股份0.12美元进行供股，以透过向合资格股东提呈最 多4,808,700股供股股份的供股方式筹集扣除开支前所得款项总额约58万美元(假设于记录日期或前概无 进一步发行或购回股份)。供股仅供合资格股东认购，将不会向除外股东提呈。 ...

Core Viewpoint - The company, Ying Sheng Science (00209), announced that it successfully accepted and applied for a total of approximately 1.039 billion shares in a rights issue, which represents about 79.92% of the total 1.3 billion shares available for subscription [1] Group 1 - The rights issue experienced a shortfall, with approximately 261 million shares remaining unsubscribed, accounting for about 20.08% of the total shares available for subscription [1] - Due to the shortfall in subscriptions, under the underwriting agreement, the underwriters facilitated the subscription of approximately 261 million shares, resulting in the total shares available for subscription being fully subscribed [1] - The total proceeds from the rights issue amounted to approximately HKD 182 million, with the estimated net proceeds after deducting underwriting commissions and other related expenses being approximately HKD 176.5 million [1]

Group 1 - The company proposes to increase its authorized share capital from HKD 50 million (5 billion shares) to HKD 400 million (40 billion shares) by issuing an additional 3.5 billion shares with a par value of HKD 0.1 each [1] - The increase in authorized share capital will take effect upon approval by shareholders at a special general meeting [1] Group 2 - The board recommends a rights issue where shareholders will receive 4 new shares for every 1 existing share held, at a subscription price of HKD 0.105 per share, representing a discount of approximately 42.86% [2] - The rights issue aims to raise up to approximately HKD 121.6 million, with a net estimated amount not exceeding HKD 62.5 million after expenses [2] - The proceeds will be allocated as follows: approximately HKD 41.2 million for repaying overdue bank loans and interest, about HKD 13.1 million for repaying shareholder loan balances, around HKD 7.7 million for settling trade and other payables, and the remaining HKD 0.5 million for general operational expenses [2]